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Abstract
The retinoblastoma (Rb) tumor suppressor acts with a number of chromatin cofactors in a wide range of species to suppress
cell proliferation. The Caenorhabditis elegans retinoblastoma gene and many of these cofactors, called synMuv B genes,
were identified in genetic screens for cell lineage defects caused by growth factor misexpression. Mutations in many
synMuv B genes, including lin-35/Rb, also cause somatic misexpression of the germline RNA processing P granules and
enhanced RNAi. We show here that multiple small RNA components, including a set of germline-specific Argonaute genes,
are misexpressed in the soma of many synMuv B mutant animals, revealing one node for enhanced RNAi. Distinct classes of
synMuv B mutants differ in the subcellular architecture of their misexpressed P granules, their profile of misexpressed small
RNA and P granule genes, as well as their enhancement of RNAi and the related silencing of transgenes. These differences
define three classes of synMuv B genes, representing three chromatin complexes: a LIN-35/Rb-containing DRM core
complex, a SUMO-recruited Mec complex, and a synMuv B heterochromatin complex, suggesting that intersecting
chromatin pathways regulate the repression of small RNA and P granule genes in the soma and the potency of RNAi.
Consistent with this, the DRM complex and the synMuv B heterochromatin complex were genetically additive and displayed
distinct antagonistic interactions with the MES-4 histone methyltransferase and the MRG-1 chromodomain protein, two
germline chromatin regulators required for the synMuv phenotype and the somatic misexpression of P granule
components. Thus intersecting synMuv B chromatin pathways conspire with synMuv B suppressor chromatin factors to
regulate the expression of small RNA pathway genes, which enables heightened RNAi response. Regulation of small RNA
pathway genes by human retinoblastoma may also underlie its role as a tumor suppressor gene.
Citation: Wu X, Shi Z, Cui M, Han M, Ruvkun G (2012) Repression of Germline RNAi Pathways in Somatic Cells by Retinoblastoma Pathway Chromatin
Complexes. PLoS Genet 8(3): e1002542. doi:10.1371/journal.pgen.1002542
Editor: Susan E. Mango, Harvard University, United States of America
Received June 9, 2011; Accepted December 30, 2011; Published March 8, 2012
Copyright:  2012 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the MGH Fund for Medical Discovery postdoctoral fellowship to XW and by grants from the National Institutes of Health
(www.nih.gov) to GR (AG16636) and to MH (GM47869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ruvkun@molbio.mgh.harvard.edu
Introduction
The tumor suppressor protein Rb (retinoblastoma) is a chromatin
factor that functions in transcriptional repression of cell cycle
regulatory genes as well as other genes. As a transcriptional
repressor, Rb functions in a core complex (dREAM/Muv B) that
binds to specific promoters and recruits a crew of repressive
chromatin cofactors to inhibit the expression of target genes [1,2].
Rb-recruited factors include repressive histone methyltransferases
(Suv39, Suv420), repressive heterochromatin proteins that bind to
methylated histones (HP-1, L3MBT), and the Nucleosome
Remodeling and Deacetylase complex (NuRD complex) [3–5].
Beyondtranscription, Rbalsointeractswith otherchromatinfactors
(e.g., condensin II) and participates in other chromatin functions
such as chromosome condensation and maintaining genome
stability [6,7]. Even though it has been studied as a cell cycle
regulator for two decades, the functions of Rb are clearly much
broader.
Rb pathway genes have been studied in the nematode C. elegans
because Rb and many of its interacting proteins identified
biochemically in flies and mammals are conserved in C. elegans
and null alleles in the corresponding C. elegans genes cause similar
developmental phenotypes [2]. Genes encoding Rb (lin-35), the
rest of the core DRM/dREAM complex, and Rb-recruited
repressive chromatin factors all belong to the class of synMuv B
(synthetic multivulva B) genes, mutations in which cause a Muv
(Multivulva) phenotype when combined with a mutation in a
synMuv A gene. synMuv B genes, along with synMuv A genes,
repress the expression of the growth factor gene lin-3/EGF in
the developing hypodermis [8]. Excess EGF (Epidermal Growth
Factor) signaling from the hypodermis in synMuv AB double
mutant animals induces multiple vulva precursor cells to adopt
the cell division patterns normally specified for only one vulval
precursor cell, causing the Muv phenotype. Rb pathway
chromatin factors comprise the bulk of the synMuv B genes as
revealed by saturation genetic analysis and whole genome RNAi
screens in synMuv A mutant strains, from which a few additional
synMuv B genes have been identified, some of which also encode
probable chromatin factors [9,10]. The genetic pathways
necessary for the Muv phenotype in synMuv AB double mutant
worms have been revealed by whole genome RNAi screens for
gene inactivations that suppress the Muv phenotype of synMuv AB
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Therefore, Rb pathway proteins function with particular chroma-
tin factors while antagonizing others to specify the production of
the LIN-3/EGF signal from particular cells during vulval
development.
Mutations in several synMuv B genes, especially those that
encode the Rb core complex also cause a dramatic enhancement
of response to dsRNA, that is enhanced RNAi (Eri) [12,13].
Inactivation of lin-35/Rb also causes enhanced transgene silencing,
a process that depends on some RNAi factors [12,13]. Eri and
enhanced transgene silencing are also caused by mutations in
distinct RNAi regulatory factors, for example, the genes eri-1 to eri-
9, that do not interact with synMuv A mutations to induce a Muv
phenotype [14,15]. lin-35/Rb likely inhibits RNAi using a distinct
mechanism from these other eri genes because null alleles in lin-35
and eri genes are genetically additive, have different genetic
requirements for canonical RNAi factors, and display specificity in
gene inactivation tests involving distinct dsRNAs [13]. One
potential mechanism of the enhanced RNAi response in synMuv
B mutants is the somatic misexpression of germline-specific genes
observed in these animals, given that many RNAi factors are
preferentially expressed in the C elegans germline which is also
more proficient at RNAi [13].
Many synMuv B mutants misexpress germline-specific P
granules in their somatic tissue [13,16,17]. Homologous to nuage
and polar granules of insects and mammals, P granules mark the
germline of C. elegans from the very first cell divisions and are
essential to the function and maintenance of the germline [18,19].
These perinuclear RNP granules harbor processing and binding
proteins for mRNAs as well as endogenous small RNAs, and are
thought to be the site of nascent mRNA export and endogenous
small RNA biogenesis and storage [20–22]. The somatic
misexpression of P granule components was first observed in
mep-1 and let-418 mutants which were found to also function in the
synMuv B pathway [17]. Unlike null mutants of most synMuv B
genes, which are viable, null mutations of mep-1 or let-418 cause L1
arrest or sterility, suggesting that the expression of germline P
granules in somatic cells can have severe developmental
consequences or that these genes also regulate other essential
functions in contrast to lin-35/Rb. The somatic misexpression of
germline P granules as well as the developmental arrest
phenotypes of mep-1 or let-418 are fully suppressed by inactivation
of three synMuv B suppressor genes, which encode germline
chromatin factors (mes-4, mrg-1, isw-1), pointing to antagonistic
chromatin factors in regulating the expression of germline genes in
the soma [11,23,24]. It was proposed that the NuRD complex,
containing LET-418, prevents somatic misexpression through
chromatin modification or remodeling and antagonizing the
function of germline specific chromatin factors [17]. Later, the
misexpression of P granules in somatic cells was shown in several
other synMuv B mutants, including lin-35/Rb, indicating a
broader involvement of synMuv B genes in this process [13].
While these synMuv B mutants are viable, all of them display high
temperature larval arrest, again suggesting severe developmental
consequences from such misexpression of normally germline-
specific genes [16]. Loss of the germline chromatin factors mes-4,
mrg-1 and isw-1, which suppresses the somatic misexpression and
high temperature larval arrest in these other synMuv B mutants,
was also shown to suppress the enhanced transgene silencing and
vulval specification phenotypes, suggesting that the somatic
misexpression of germline components contributes to the en-
hanced RNAi and the vulval cell fate change in these animals
[13,16,23–25]. The inappropriate expression of germline genes
including small RNA pathway components could also contribute
to the oncogenicity of loss of Rb in mammalian cells.
Both the enhanced RNAi and the expression of germline-
specific genes in soma uniquely reflect the function of the synMuv
B pathway, as they are not present in mutants of other synMuv
classes. However, not all synMuv B mutants are Eri or show PGL-
1 misexpression, suggesting functional specialization. Moreover,
only some of the Muv suppressing chromatin factors affect RNAi
and only three (mes-4, mrg-1, isw-1) suppress PGL-1 misexpression
[11]. Thus, the genetic pathways underlying Eri and the
expression of germline genes in somatic cells remain to be further
investigated.
Here we use response to RNAi, subcellular analysis of somatic P
granules, and characterization of somatic misexpression of germ-
line-specific genes to reveal that synMuv B genes constitute distinct
intersecting axes for the repression of germline genes in somatic
cells. We find that these chromatin factors regulate the expression
of partially overlapping sets of germline target genes, including
genes that encode annotated small RNA cofactors such as
Argonaute proteins, and P granule components such as helicases
and RNA binding proteins. The three synMuv B chromatin
complexes we find are the LIN-35/Rb-containing core complex
(DRM), the SUMO-mediated Mec complex (rather than the
previously suspected NuRD complex), and a synMuv B hetero-
chromatin complex, representing distinct classes of synMuv B
mutants. We show that the DRM and synMuv B heterochromatin
complexes each have distinct requirements for MES-4 function,
suggesting different placements in the genetic pathway. We
present a model of how synMuv B complexes collectively inhibit
RNAi and prevent germline gene expression in the soma.
Results
Three synMuv B functional classes based on molecular
and biochemical association
The majority of synMuv B genes revealed by saturation genetic
and RNAi screens encode chromatin factors that belong to
three functional classes: the DRM complex, a predicted NuRD
Author Summary
In metazoans, soma and germline have specialized
functions that require differential tissue-specific gene
expression. In C. elegans, explicit chromatin marks depos-
ited by the MES-4 histone methyltransferase and the MRG-
1 chromodomain protein allow germline expression of
particular suites of target genes. Conversely, the expres-
sion of germline-specific genes is repressed in somatic cells
by other chromatin regulatory factors, including the
retinoblastoma pathway genes. We characterized the
distinct profiles of somatic misexpression of normally
germline-specific genes in these mutants and mapped out
three chromatin complexes that prevent misexpression.
We demonstrate that one of the complexes closely
counteracts the activity of MES-4 and MRG-1, whereas
another complex interacts with additional regulators that
are yet to be identified. We show that these intersecting
chromatin complexes prevent the upregulation of a suite
of germline-specific as well as ubiquitous small RNA
pathway genes, which contributes to the enhanced RNAi
response in retinoblastoma pathway mutant worms. We
suggest that this function of the retinoblastoma pathway
chromatin factors to prevent germline-associated gene
expression programs in the soma and the upregulation of
small RNA pathways may also underlie their role as tumor
suppressors.
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worm DRM complex (dREAM/MMB in flies and DREAM in
mammals) consists of LIN-35/Rb, the Rb binding protein LIN-
53/RbBP4, the transcription factor dimer EFL-1/E2F4-DPL-1/
DP1, and homologues of Myb-interacting proteins LIN-9/
Mip130, LIN-54/Mip120 and LIN-37/Mip40 [3,26–28]. LIN-
53/RbBP4 is a shared component with the mammalian NuRD
complex. The C. elegans NuRD complex has not been biochem-
ically defined, but homologues of mammalian NuRD have
emerged from genetic analyses. For example, genes encoding the
histone deacetylase HDA-1/Rpd3 and the ATP-dependent
chromatin remodeling enzyme LET-418/Mi-2 act in synMuv B
pathways [17,29,30]. Although MEP-1 is not part of the
mammalian NuRD due to the lack of an obvious homologue, it
physically and functionally interacts with LET-418 in worms and
flies [17]. synMuv B heterochromatin proteins include histone
methyltransferases MET-1 and MET-2, methyl histone binding
proteins HPL-2/HP1 and LIN-61/L3MBT, and the multiple zinc
finger protein LIN-13, which mediates HPL-2 localization via
physical interaction [31–34]. The molecular functions of the
remaining synMuv B proteins are less known. These include LIN-
15B, LIN-36, TAM-1, RPB-11, E01A2.4, GEI-4 and LIN-65
[9,10,35–38].
Phenotypic classification of synMuv B genes
Many synMuv B mutants show an enhanced RNAi (Eri)
phenotype and PGL-1 misexpression in somatic cells, but some do
not (Figure S1 and [11–13,16,17,31,33,39,40]). Even among the
mutants that show enhanced RNAi and misexpress P granules, we
noticed significant phenotypic differences, including strongly vs.
weakly enhanced RNAi (Figure 1A), enhanced transgene silencing
vs. transgene desilencing (Figure 1B, 1C), and large sparsely
distributed vs. small densely clustered PGL-1 granules that are
misexpressed in the intestine (Figure 1D). These differences suggest
functional specializations among synMuv B proteins, and may
reflect distinct activities from individual functional classes. To test
this, we systematically surveyed and classified all synMuv B genes
based on these phenotypes.
As shown in Figure S2, the phenotypic differences segregated
coherently and could be used to classify synMuv B mutants into
three distinct classes. Null or strong mutations in all but one of the
seven DRM components strongly enhanced response to dsRNA
causing a strong enhanced RNAi phenotype (close to 100% RNAi
phenotype, Figure 1A), enhanced transgene silencing (Figure 1B)
and caused the somatic misexpression of PGL-1 granules that were
large and sparsely distributed around the nucleus of intestinal cells,
as revealed by immunofluorescence imaging (Figure 1D). The only
exception was efl-1/E2F, which was previously reported not to
cause enhanced RNAi and PGL-1 misexpression [12,16]. We also
did not observe any phenotype upon inactivation of efl-1,
suggesting that EFL-1 is redundant or may not participate in all
the activities of the DRM complex.
In sharp contrast, null or strong mutations in the synMuv B
heterochromatin class genes induced a noticeably weaker en-
hanced RNAi phenotype (60% or barely detectable RNAi
phenotypes, Figure 1A), transgene desilencing, which is exactly the
opposite from the transgene silencing phenotype of the DRM
complex factors (Figure 1C), and somatic misexpression of PGL-1
granules that were much smaller and densely clustered around the
nucleus in intestinal cells (Figure 1D). The only exception is met-1,
which had no detectable phenotype, suggesting a specific
involvement of H3K9 methylation (catalyzed by MET-2) but
not H3K36 methylation (catalyzed by MET-1) [31,41,42]. One
interesting feature of this class is the decoupling between feeding
RNAi efficiency and transgene silencing ability. It suggests that
either these proteins inhibit a unique aspect of feeding RNAi, or
they have additional roles in transgene silencing (see below).
Results for the synMuv B NuRD components were distinct from
the other gene classes. Only transgene silencing and PGL-1
misexpression in the soma were assayed due to sterility/lethality
associated with these mutants. RNAi inactivation of mep-1 caused
enhanced transgene silencing, whereas inactivation of hda-1 or let-
418 had no effect, suggesting that MEP-1 may function separately
in transgene silencing. As reported [17], inactivation of let-418
and mep-1 caused somatic PGL-1 misexpression. However, the
misexpressed PGL-1 granules were small and densely clustered
around the nucleus, as in the case of the heterochromatin class of
synMuv B mutants but distinct from the DRM class mutants.
Intriguingly, neither hda-1 mutant nor hda-1 RNAi treated worms
showed detectable misexpression of PGL-1 in the soma
(Figure 1D), suggesting that either the histone deacetylase activity
of NuRD is not required, or MEP-1 and LET-418 function outside
the context of NuRD in preventing germline gene expression in
the soma (see below).
Among the less studied synMuv B genes, we found that lin-15b
mutant worms showed strongly enhanced RNAi (Figure 1A),
enhanced transgene silencing (Figure 1B), and misexpressed large
PGL-1 granules that are sparsely distributed around the nucleus
(Figure 1D), resembling mutants of the DRM complex (Figure 1E).
On the other hand, inactivating lin-65 led to weakly enhanced
RNAi (Figure 1A), transgene desilencing (Figure 1C), and
misexpressed small PGL-1 granules that are densely clustered
(Figure 1D), resembling the synMuv B heterochromatin class
(Figure 1E). Inactivation of tam-1 caused weakly enhanced RNAi,
transgene silencing, but no PGL-1 misexpression, and thus may
function independently in inhibiting only RNAi (Figure 1E). No
phenotype was observed upon inactivating lin-36, rpb-11, E01A2.4
or gei-4, suggesting that they may not be involved in inhibiting
RNAi or repressing germline genes in soma but rather may be
involved in other aspects of vulva precursor cell specification
(Figure 1E).
Individual synMuv B classes distinctly repress RNAi and P
granule genes
To test whether each synMuv B gene class differentially
represses the expression of germline genes in somatic cells in
general, we sought to identify molecular targets of each class.
Given the enhanced RNAi and pgl-1 misexpression phenotypes,
we first inspected the microarray studies of lin-35 mutant animals
for somatic misexpression of known P-granule and RNAi genes
[43,44]. We focused on the larval stage one (L1 stage) microarray
comparisons between wild type and lin-35 null mutant animals
because at that stage the germline has two quiescent cells and the
soma has 550 cells. As verified in our analyses below, any
misexpression of germline genes in somatic tissues at this stage
would be more readily observed than at later stages, where a
genetic ablation of the germline would be necessary. Because of
the distinct features of enhanced RNAi and somatic misexpression
of P granules in the various classes of synMuv B mutants, we
expected that particular suites of germline components might be
misexpressed in each class of synMuv B mutants.
pgl-1 was dramatically upregulated at the L1 stage in two
microarray studies of lin-35/Rb mutant larvae. In addition, three
other genes known to encode P granule components, glh-1, pgl-3
and spn-4, were also upregulated (Figure S3B), suggesting that the
somatic misexpression of P granule components stems from
transcriptional misregulation of germline genes in the somatic cells
of the lin-35/Rb mutant. In fact, as shown in Figure S3A, out of
Chromatin Complexes Repress Germline RNAi Pathways
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(86 genes) were identified as more than 2-fold germline-enriched
by microarray [45],representing a 4.6-fold enrichment over the
entire genome (1584 genes, 8.3%). Similarly, 18.6% (57 genes) of
the lin-35 L1 up genes were identified as germline-specific or
germline-enriched by SAGE [46], a 3.3-fold enrichment over the
entire genome (1063 genes, 5.6%). These analyses point to a
striking preference of germline-enriched genes among the
upregulated genes in these synMuv B mutants, which highlights
the targeting of synMuv B genes to the repression of germline
genes in somatic cells.
We next looked for RNAi factors that were upregulated, which
may contribute to the enhanced RNAi phenotypes. None of the
genes encoding canonical RNAi factors such as rde-1 or dcr-1 were
upregulated in any of the arrays, consistent with previous studies
[11]. However, we found several genes encoding less well studied
RNAi factors to be upregulated (Figure S3B). Among them,
C16C10.3/wago-9, mut-2, drh-3, rde-4 and csr-1 are normally
germline enriched [45,46], and thus likely represent germline
genes that are misexpressed in the soma. Four genes C04F12.1,
sago-2, rrf-2 and drh-1 are not germline-enriched [45,46], and thus
represent ubiquitous RNAi factors that are upregulated.
We carried out real-time RT-PCR experiments to confirm the
upregulation of these genes in lin-35/Rb mutants, and to test
whether the same upregulations occur in mutants of other synMuv
B classes. To specifically detect upregulation in the soma, the glp-
4(bn2) temperature sensitive mutant was used, which ablates
germline development at 25C. We were able to verify more than
two-fold upregulation for 11 out of the 13 candidate somatically
expressed germline genes in glp-4 lin-35 mutants. Two genes, csr-1
and drh-1, showed only marginal upregulation (less than two fold),
and were not analyzed further.
We tested whether the same upregulations occur when
inactivating other synMuv B classes. Specifically, we individually
inactivated known components of each class, either by genetic
mutation or by RNAi knockdown, and measured the expression of
these 11 genes in the soma. Of these eleven genes, seven were
upregulated upon the inactivation of most components of all three
synMuv B classes. These include the P granule genes pgl-1, pgl-3
and glh-1, the germline enriched RNAi gene C16C10.3/wago-9
(common germline targets), and all three ubiquitously expressed
RNAi genes C04F12.1, sago-2 and rrf-2 (common ubiquitous
targets) (Figure 2A, 2B and Figure S4). Somatic upregulations
ranged from several fold to several hundred fold, but for a given
gene, the extent of upregulation was largely similar among
different synMuv B mutants. Interestingly, despite no enhanced
RNAi or PGL-1 misexpression phenotypes, inactivation of efl-1
induced upregulation of glh-1, pgl-3 and C16C10.3/wago-9 (Figure
S4), suggesting that EFL-1 participates in the repression of some
but not all DRM target genes.
Four germline-enriched genes, spn-4, mut-2, drh-3 and rde-4,
showed DRM-specific upregulation (DRM-specific targets)
(Figure 2C and Figure S4). Compared to glp-4 control, these
genes were upregulated 4–16 fold in lin-35 glp-4 mutants and upon
RNAi knockdown of lin-9, lin-54 or lin-52 in eri-1; glp-4 mutants.
spn-4 was also upregulated in glp-4 worms treated with efl-1(RNAi).
Consistent with its classification as a DRM class mutant based on
P granule morphology and enhanced RNAi, inactivation of lin-15b
caused upregulation of all seven common targets, and a DRM-
specific target spn-4 (Figure 2C). None of these DRM-specific
target genes were upregulated in mep-1 or let-418 inactivations (by
RNAi in eri-1; glp-4 mutants), nor in any of the synMuv B
heterochromatin inactivations (in glp-4; hpl-2 or glp-4 lin-61
mutants, or upon RNAi knockdown of lin-13 or met-2 in eri-1;
glp-4 mutants) (Figure 2C and Figure S4). These results suggest
that somatic repression of these genes solely depends on the DRM
complex but not the synMuv B heterochromatin factors or MEP-
1-LET-418 proteins.
The DRM-specific upregulations prompted us to look for genes
that might be specifically upregulated in synMuv B heterochro-
matin or mep-1-let-418 mutants. We focused on germline-enriched
Argonaute genes that were not upregulated in lin-35 microarrays
because of the central position of Argonaute genes in small RNA
pathways. A limited survey of these genes showed that R06C7.1/
wago-1 and F55A12.1/wago-10 were significantly upregulated in
almost all inactivations of the synMuv B heterochromatin class
genes and mep-1 & let-418 (Figure 2D and Figure S4). In contrast,
no significant upregulation of these Argonaute genes was detected
in any of the DRM class synMuv B gene inactivations (Figure 2D
and Figure S4). Therefore, the synMuv B heterochromatin class
and MEP-1-LET-418 proteins are uniquely required to repress a
specific set of germline-enriched RNAi factors in somatic cells.
We also extended the gene expression analyses to the remaining
synMuv B genes. Inactivation of either lin-15b or lin-65 led to the
misexpression of common germline and common ubiquitous
targets (Figure 2A, 2B). However, as shown in Figure 2C and 2D,
inactivating lin-15b caused upregulation of spn-4 (DRM -specific
target), but not R06C7.1/wago-1 or F55A12.1/wago-10 (hetero-
chromatin- and MEP-1&LET-418-specific targets). In contrast,
inactivation of lin-65 led to the upregulation of R06C7.1/wago-1
and F55A12.1/wago-10, but only very marginal upregulation of
spn-4 and no upregulation of the other three DRM-specific targets.
These gene expression patterns again place lin-15b into the DRM
class genes while lin-65 into the heterochromatin class, consistent
with the previous phenotypic classification.
For synMuv B genes that did not show PGL-1 misexpression or
enhanced RNAi phenotypes in the phenotypic classification, most
of the inactivations led to no or very modest upregulations of these
P granule or RNAi factors (Figure S4). The only exception is gei-4,
whose inactivation led to the upregulation of several target genes.
However, the most impressive upregulations observed were for the
ubiquitous common targets, suggesting that gei-4 may be more
specifically involved in the repression of ubiquitous targets.
In summary, the three classes of synMuv B proteins function to
repress overlapping sets of P granule and RNAi genes. The
different spectra of misexpression suggest overlapping as well as
Figure 1. Distinct synMuv B mutant classes affect RNAi and PGL-1 misexpression differently. (A) RNA interference responses to gene
inactivations that are poor in wild type but enhanced in synMuv B mutants. L1 animals of the indicated genotype were fed E. coli expressing dsRNA
for the listed tester genes and phenotypes were scored in the next generation (F1). % L2 arrest represents the percentage of F1 animals arresting at
L2 stage. % lethality represents the percent reduction of F1 progeny from animals treated with RNAi compared to control. (B) Mutants of the DRM
complex displayed enhanced transgene silencing. L3 animals with indicated genotypes carrying a sur-5::gfp transgene were imaged for gfp
expression. (C) Inactivation of synMuv B heterochromatin class genes causes transgene desilencing. eri-1(mg366); sur-5::gfp animals treated with the
indicated RNAi were imaged for gfp expression at the L3 stage. Arrows point to intestinal nuclei with brighter GFP expression indicating transgene
desilencing. (D) Different PGL-1 misexpression phenotypes displayed by representative mutants. L4 or young adult animals were stained with anti-
PGL-1 antibody K76 (yellow) and DAPI (blue). Arrows point to the intestinal nuclei whose PGL-1 staining patterns are shown in the insets. (E) Summary
of the classification of synMuv B genes based on phenotypes. *: excluding efl-1. n.d.: not determined.
doi:10.1371/journal.pgen.1002542.g001
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PLoS Genetics | www.plosgenetics.org 5 March 2012 | Volume 8 | Issue 3 | e1002542Figure 2. Different synMuv B classes distinctly repress P granule and RNAi genes in the soma. Real-time RT-PCR assays were performed
using L4 stage worms with the indicated genotype or RNAi treatment. Expression levels were compared to that of glp-4 worms and fold
upregulations are plotted on the Y-axis. An asterisk indicates that the synMuv B gene was inactivated by RNAi in glp-4(bn2); eri-1(mg366) double
mutant animals and expression levels were compared to that of vector control treated animals. Fold upregulations represent target expression in the
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underlie the distinct enhanced RNAi and transgene silencing
phenotypes, and the distinct somatic P granule architectures
observed in these mutants.
The Mec complex, not NuRD, prevents germline gene
expression in somatic cells
The observation that loss of hda-1, one of the catalytic subunits
of the NuRD complex, does not induce somatic PGL-1 mis-
expression suggests that the entire complex is not required. To
discern which NuRD subunits might be required, we surveyed the
annotated C. elegans homologues of the NuRD complex for somatic
P granule misexpression. We tested loss of function mutations and
gene inactivations by RNAi of egr-1 and egl-27 (MTA homologues),
dcp-66 (p66 homologue), chd-3 (let-418 Mi2 paralogue) and rba-1
(lin-53 RBBP4 paralogue). We detected no somatic PGL-1
misexpression in any of the inactivations (Figure 3A), suggesting
that NuRD is not involved. Consistent with this, loss of lin-53,a
shared component between the DRM complex and the presumed
NuRD complex, caused PGL-1 misexpression with a pattern that
resembles that in the DRM mutants and differs from that in mep-1
or let-418 mutants. Thus, MEP-1 and LET-418 appear to function
independently of NuRD in preventing somatic PGL-1 expression.
Recent work in flies has revealed that dMEP-1 and dLET-418
form a stable complex named dMec, which recognizes SUMO
modifications on transcription factors and carries out transcrip-
tional repression [47,48]. C. elegans MEP-1 was reported to
recognize and bind SUMO modified transcription factor LIN-1
and help repress LIN-1 target genes [49]. To test whether
repression of PGL-1 misexpression required SUMO and a
homologous Mec complex, we tested whether the SUMO pathway
is required. Indeed, inactivation of the genes encoding the SUMO-
activating enzyme (uba-2), the SUMO conjugation enzyme (ubc-9),
and SUMO itself (smo-1) all caused somatic PGL-1 misexpression
(Figure 3A). More importantly, the misexpressed PGL-1 form
small granules that are densely clustered around the nucleus,
identical to those in mep-1 and let-418 mutant worms (Figure 3A).
This result strongly supports the idea that in worms, MEP-1 and
LET-418 prevent somatic PGL-1 misexpression as subunits of the
Mec complex that requires SUMO modification of target
transcription factors or chromatin factors, rather than as
components in a NuRD complex.
We next examined whether the SUMOylation machinery also
regulates the other germline RNAi components that are responsive
to mep-1 and let-418. Using real-time RT-PCR, we tested the effect
of hda-1 and smo-1 on the repression of other target genes. As
shown in Figure 3B and Figure S4, loss of smo-1, but not hda-1,
caused somatic misexpression of glh-1, pgl-3 and C16C10.3/wago-9
(common germline targets) as well as R06C7.1/wago-1 and
F55A12.1/wago-10 (synMuv B heterochromatin and MEP-1 and
LET-418-specific targets). The same treatment did not lead to the
upregulation of spn-4, rde-4, mut-2, and drh-3 (DRM-specific
targets), indicating that smo-1 is specifically required for the
repression of MEP-1/LET-418 target genes. Interestingly, smo-
1(RNAi) failed to induce the upregulation of C04F12.1 and sago-2,
and only weakly upregulated rrf-2 (common ubiquitous targets),
suggesting that the SUMO pathway may be specifically required
to repress germline genes. Inactivation of hda-1 by RNAi did not
lead to significant upregulation of any of the germline genes tested
(Figure 3B and Figure S4), again supporting that the NuRD
complex is not involved in repressing germline targets in the soma.
On the other hand, hda-1(RNAi) did lead to a modest upregulation
of ubiquitous targets C04F12.1 and rrf-2 (Figure 3B and Figure S4),
suggesting that the NuRD complex may contribute to the
repression of ubiquitous target genes.
The above results strongly suggest that it was the Mec complex,
not the NuRD, that is required for preventing misexpression of
germline genes in somatic cells. As in flies, the worm Mec complex
may mediate transcriptional repressive effects of SUMO modifi-
cations on relevant transcription factors or chromatin factors.
A synMuv B heterochromatin complex with unique
functions
Phenotypic and gene expression analyses suggest that the class
of synMuv B heterochromatin proteins likely function together,
and in the case of transgene expression, act separately from the
DRM or the Mec complexes. Consistent with acting separately
from the DRM and the Mec complexes, members of the synMuv
B heterochromatin class have distinct cytological localizations.
GFP fusions to LIN-13 and HPL-2 form subnuclear foci that may
correspond to compact heterochromatin [32,34]. In contrast,
DRM complex components and GFP fusions to MEP-1 or LET-
418 showed uniform nuclear localization [26,50–53].
We tested whether the synMuv B heterochromatin proteins
physically function together cytologically and biochemically. We
constructed a GFP fusion to the full length LIN-61/L3MBT
protein and observed its subcellular localization. LIN-61::GFP
rescued the Muv, enhanced RNAi and PGL-1 misexpression
phenotypes of lin-61(tm2649) mutant animals, and thus is a
functional fusion protein (data not shown). GFP expression was
detected by western analysis in all stages of worm development.
Expression was the highest in embryos, where GFP was visible in
most cells.
LIN-61::GFP showed nuclear localization with concentrated
foci, just like LIN-13::GFP and HPL-2::GFP (Figure 4A). To look
at the relationship between LIN-61::GFP foci and DNA, we
costained LIN-61::GFP embryos with anti-GFP and DAPI. As
shown in Figure 4B, anti-GFP antibody revealed foci resembling
those formed by live GFP. Moreover, the most intensely stained
GFP foci colocalize with areas of low DAPI staining, which is very
similar to the reported pattern for HPL-2::GFP in interphase
nuclei [32]. LIN-61::GFP was specifically depleted in nuclei with
condensed chromosomes that are probably undergoing mitosis
(Figure 4B), which was also observed for LIN-13::GFP (data not
shown). The similar cytological localizations suggest that LIN-61
may colocalize with LIN-13 and HPL-2 in the nucleus. We thus
generated a rescuing LIN-61::3xFLAG fusion gene (data not
shown) and simultaneously visualized both LIN-61::3xFLAG and
LIN-13::GFP fusion proteins in embryos by double immunostain-
ing. As shown in Figure 4C, both LIN-61::3xFLAG and LIN-
13::GFP localized to subnuclear regions that ranged from con-
centrated localization to discrete foci, and mostly coincided with
poor DAPI staining (data not shown). Most importantly, in cells
coexpressing both fusion proteins, FLAG and GFP signals largely
overlapped, consistent with a colocalization. However, unlike
HPL-2::GFP foci, which depend on LIN-13 and disappear in the
absence of lin-13, LIN-61::GFP foci were not affected by the loss of
lin-13 (data not shown), suggesting a different mechanism of
soma, except for those in wild type animals, which represent the germline-enriched nature of the target gene. Asterisks represent greater than 2-fold
mean fold change and with a p-value of less than 0.05 in two-tailed t-tests. Target genes were categorized into (A) germline-specific common targets,
(B) ubiquitously expressed common targets, (C) DRM-specific targets, (D) synMuv B heterochromatin and MEP-1-LET-418 specific targets.
doi:10.1371/journal.pgen.1002542.g002
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directly bind to H3K9 methylation marks, just like HPL-2 [54],
which may serve as the basis of colocalization.
To test whether LIN-61 physically interacts with other synMuv
B heterochromatin proteins, we identified LIN-61-interacting
proteins using large scale immunoprecipitation followed by mass
spectrometry analysis. Embryos expressing LIN-61::GFP were
used. Mass spectrometry analysis identified significant peptide
coverage for LIN-13 and HPL-2, which was absent from a parallel
IP using untagged control embryos (Figure S5). This indicates that
LIN-13 and HPL-2 were present in the immunoprecipitants and
thus likely physically interacted with LIN-61 (Figure 4D).
Although peptides corresponding to additional proteins were
identified (X. Wu and G. Ruvkun, unpublished), none corresponds
to components of the DRM or Mec complex. These results suggest
that synMuv B heterochromatin proteins LIN-61, LIN-13 and
HPL-2 form a complex that is distinct from the DRM or the Mec
complex.
The interactions between LIN-61 and LIN-13 as well as
between LIN-61 and HPL-2 were confirmed using coimmuno-
precipitation-Western analyses. To this end, in addition to the
LIN-61::3xFLAG fusion described above, we also generated a
rescuing LIN-54::3xFLAG fusion gene (data not shown). LIN-
13::GFP or HPL-2::GFP fusion proteins immunoprecipitated the
coexpressed LIN-61::3xFLAG protein (Figure 4E). LIN-61::GFP
fusion protein also immunoprecipitated LIN-61::3xFLAG, sug-
gesting that there are more than one LIN-61 protein present in the
immunoprecipitant, presumably reflecting a higher order packag-
ing potential of heterochromatin proteins either by the self-
dimerization potential of LIN-61/L3MBT proteins or of other
members of this complex [5,55]. By contrast, the LIN-
54::3xFLAG protein was not detected in the LIN-13::GFP or
LIN-61::GFP precipitates, and only weakly detected in the HPL-
2::GFP precipitate, again pointing to the existence of a distinct
heterochromatin complex, which may only weakly interact with
other synMuv B chromatin complexes such as the DRM complex.
It is intriguing that the synMuv B heterochromatin mutants
desilence transgenes, despite having enhanced RNAi response.
This contradicts the general positive correlation between RNAi
efficiency and the ability to silence transgenes, where enhanced
RNAi efficiency often leads to enhanced transgene silencing while
a deficiency in RNAi response usually leads to desilencing of
transgenes [14,15,56]. Our analysis of double mutants showed that
the transgene desilencing phenotype of synMuv B heterochroma-
tin mutants was epistatic to a range of other enhanced RNAi
mutants that also silence transgenes. Inactivation of synMuv B
heterochromatin class genes reversed the transgene silencing
induced by eri-1 mutations, DRM class synMuv B mutations and
the natural silencing in the germline of wild type C. elegans worms
(Figure S6 and data not shown). Thus, the heterochromatin class
of synMuv B proteins is uniquely required for transgene silencing,
likely downstream or in parallel to their effects on RNAi efficiency.
Similar to repetitive transgenes, silencing of endogenous repetitive
gene clusters in the genome may also require both the small RNA-
mediated silencing and the downstream or parallel actions of these
heterochromatin factors. It is possible that the presence of
heterochromatin proteins at the repetitive loci may in turn recruit
additional small RNA factors to continue small RNA-mediated
silencing, as has been suggested in yeast for the spreading of
heterochromatin [57,58]. Thus, in addition to the transcriptional
upregulation of RNAi factors, the loss of silencing at endogenous
repetitive gene clusters and the release of small RNA factors such
as Argonaute proteins to the exogenous RNAi pathway may also
contribute to the enhanced RNAi effect in these heterochromatin
mutants.
DRM and Muv B heterochromatin complexes provide
nonoverlapping functions
The phenotypic differences between DRM and heterochroma-
tin classes of synMuv B mutants suggest that the two complexes
may affect RNAi and the repression of germline genes in the soma
through different pathways. We tested this possibility using a
genetic approach, that is, genes that function in separate pathways
should be additive to each other when testing null allele
combinations. We first looked at feeding RNAi efficiency of
DRM; synMuv B heterochromatin double mutants. To allow the
detection of further enhanced RNAi, we used conditions where
strong Eri mutants only showed a partial phenotype. We found
that diluting 2 parts of the cel-1(RNAi) culture with 1 part of vector
control RNAi culture dramatically reduced the RNAi response,
reducing the nearly 100% L2 arrest phenotype in lin-35 mutants to
only ,5%. Under this condition, lin-35; hpl-2 and lin-35 lin-61
double null mutants showed significantly stronger RNAi response
(,40% to ,60% L2 arrest) compared to either single null mutant,
indicating that the synMuv B heterochromatin mutations and lin-
35 are additive (Figure 5A, left panel). The same is true when using
myo-2(RNAi) as tester: while 0% to 2% single mutants scored
showed L1 arrest, over 14% to 25% of the double mutants showed
L1 arrest (Figure 5A, middle panel). Consistent with lin-15b being
classified with the DRM complex, additivity was also observed in
heterochromatin; lin-15b double mutants using the diluted cel-1(RNAi)
assay (Figure 5A, left panel) or his-14(RNAi) as tester (Figure 5A,
right panel). Since the mutations assayed were all presumed null
alleles, the additivity in double mutants suggests that the DRM
and synMuv B heterochromatin genes function in separate
pathways.
To see whether DRM and synMuv B heterochromatin proteins
prevent gene misexpression via the same pathway or separate
pathways, we assayed the misexpression of target genes that are
commonly upregulated in both single mutants (Figure 5B).
Compared to treatment with vector control RNAi, glp-4; hpl-2
mutant animals treated with lin-35(RNAi) displayed higher levels of
misexpression of glh-1 (germline targets), as well as rrf-2 (ubiquitous
targets). More importantly, the observed higher levels of
misexpression exceeded those in glp-4 lin-35 mutant animals, thus
represent true additivity. Similar treatment with lin-15b(RNAi) also
led to significant higher levels of misexpression, whereas treatment
with hpl-2(RNAi) or lin-61(RNAi) did not. Results for other
Figure 3. MEP-1 and LET-418 function as the Mec complex to prevent somatic germline gene expression by mediating the
repressive effect of sumoylation. (A) SUMO, but not NuRD, is required to prevent somatic PGL-1 misexpression. Mixed stage animals with the
indicated genotype or RNAi treatment were subjected to anti-PGL-1 immunostaining, and the percentages of animals showing somatic expression
were plotted. n equals the total number of animals being assayed. Images of anti-PGL-1 stained animals were shown on the right. Arrows point to
misexpressed PGL-1 granules in the intestine. Note the densely clustered small granules in RNAi treated animals. (B) SUMO, but not NuRD, is required
to repress other germline-specific targets. Real-time RT-PCR assays were performed using L4 stage glp-4 worms with the indicated RNAi treatment.
Expression levels were compared to that of glp-4 worms treated with control RNAi, and fold upregulations were plotted on the Y-axis. Fold
upregulations represent target expression in the soma.
doi:10.1371/journal.pgen.1002542.g003
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levels of misexpression were detected upon lin-35(RNAi) or lin-
15b(RNAi) treatment in glp-4; hpl-2 mutant animals, the higher
levels did not significantly exceed those in glp-4 lin-35 or glp-4; lin-
15b animals, respectively (data not shown), possibly due to the
much milder upregulation from the hpl-2 mutation than from the
lin-35 or lin-15b mutation and the incomplete knockdown of lin-35
or lin-15b activity by RNAi. Conversely, glp-4 lin-35 mutant
animals treated with hpl-2(RNAi) or lin-61(RNAi) displayed higher
levels of misexpression of glh-1 and rrf-2, consistent with additivity.
Interestingly, treatment with lin-15b(RNAi) also led to a significant
higher misexpression in glp-4 lin-35 mutants, suggesting that lin-
15b likely has additional functions beyond the DRM complex.
Overall, the observed additive upregulations suggest that even
though the DRM complex and synMuv B heterochromatin
complex repress a common set of genes, they do so by providing
nonoverlapping functions.
Inactivation of mes-4 or mrg-1 preferentially suppressed
synMuv B heterochromatin mutants
Genetic suppressors of synMuv B mutations have emerged from
screens for suppression of the Muv phenotype or screens for
suppression of the enhanced RNAi phenotype [11,13,23]. Most of
these suppressor mutations correspond to other chromatin factors
that may counteract the action of synMuv B chromatin proteins. A
few of the chromatin-related suppressors suppressed multiple
phenotypes associated with synMuv B mutants [11,13,23],
suggesting that they may function antagonistically at target loci
with synMuv B proteins. Given that the DRM complex and the
synMuv B heterochromatin complex likely provide non-overlap-
ping functions, it is important to know whether these broad-
spectrum suppressors counteract all synMuv B activities, including
those provided by different complexes.
We addressed this question in the context of the somatically
misexpressedP-granuleandRNAi factors.Weasked whether RNAi
inactivation of two suppressors of both the PGL-1 misexpression
and the enhanced RNAi phenotypes (mes-4 and mrg-1) and two Eri-
specific suppressors (zfp-1 and gfl-1) can reverse the transcriptional
upregulation observed in lin-35 and hpl-2 mutants. Inactivation of
zfp-1 orgfl-1didnotsuppress any ofthetranscriptional upregulation
(data not shown), suggesting that they do not antagonize the
function of synMuv B complexes at the level of target transcription.
Instead, they might be directly involved in the RNAi process and
thus function downstream of the upregulation of P granule and
RNAi factor genes. In contrast, inactivation of mes-4 (Figure 6A, 6B)
and mrg-1 (data not shown) suppressed the upregulation of the P
granule and RNAi factor genes that are common to both DRM
complexandsynMuvBheterochromatinclass.However,atleastfor
the common germline targets (Figure 6A), the suppression was more
complete in hpl-2 mutants than in lin-35 mutants, suggesting
preferential suppression.
We explored this possibility by analyzing the effect of mes-4 and
mrg-1 inactivations on target genes that are unique to individual
synMuv B classes. As shown in Figure 6C, mes-4(RNAi) had no
effect on the upregulation of DRM-specific targets spn-4, mut-2 and
rde-4. But rather, it fully suppressed the upregulation of synMuv B
heterochromatin class-specific targets R06C7.1/wago-1 and
F55A12.1/wago-10 (Figure 6D). mrg-1(RNAi) gave identical results
(data not shown). The preferential suppression of target gene
misexpression in the heterochromatin class synMuv B mutants
further support functional specializations between individual
synMuv B classes, and strongly suggest that the heterochromatin
class synMuv B proteins specifically antagonize the activity of
MES-4&MRG-1.
Transcriptional misregulations contribute to the
enhanced RNAi phenotype
Upregulation of RNAi factors was only observed in synMuv B
mutants that exhibit enhanced RNAi, suggesting that the elevated
levels of these RNAi factors contribute to the enhanced RNAi
phenotype. We explored this possibility by two means. First, RNAi
factors that are commonly upregulated in synMuv B enhanced
RNAi mutants include three Argonaute proteins and an RNA-
dependent RNA polymerase, all of which are predicted to promote
siRNA accumulation. We measured the siRNA levels in synMuv B
mutants after pos-1(RNAi). pos-1 siRNAs accumulated to signifi-
cantly higher levels in synMuv B mutants than in wild type animals
(Figure 7A). The increase correlates with the strength of enhanced
RNAi response: 3.8- and 3.0-fold in the strong enhanced RNAi
mutants lin-35 and lin-15b vs. 2.6- and 1.4-fold in the weaker
enhanced RNAi mutants hpl-2 and lin-61. Increased siRNA levels
are likely the result of transcriptional upregulation of RNAi factors,
since it was not observed in eri-1 mutants (Figure 7A).
Second, we asked whether the upregulated RNAi factors are
required for the enhanced RNAi phenotype in synMuv B mutants.
To this end, we introduced mutations of these RNAi factors into lin-
35 or lin-15b mutants, and asked if RNAi efficiency was attenuated
in the double mutants. As shown in Figure 7B, mutations in sago-2
and rrf-2 mildly reduced RNAi efficiency in lin-35 and lin-15b
mutants.Mutation inC04F12.1 alsomildly reduced RNAiefficiency
in lin-15b mutants. Since mutations of sago-2 and rrf-2 on their own
had little or no effect on RNAi efficiency [59,60], the observed
effects are specific to synMuv B mutants. The strain carrying a
mutation in C16C10.3/wago-9 has weakly enhanced RNAi and was
additive to the synMuv B mutations in the double mutant, and was
thus not suitable for this analysis (data not shown). We also tested
whether forced overexpression of these RNAi factors would be
sufficient to cause enhanced RNAi. Overexpression of the RNAi
factors individually using sur-5 promoter-driven high copy trans-
genes did not lead to detectable enhanced RNAi (data not shown).
When tried to overexpress all four factors, we did not achieve
systemic overexpression, and the resulting strain was not Eri (data
not shown). Overall, we conclude that transcriptional upregulation
of RNAi factors likely contribute to the enhanced RNAi phenotype
in synMuv B mutants, and that robustly enhanced RNAi response
may require simultaneous upregulation of multiple RNAi factors.
Figure 4. A synMuv B heterochromatin complex. (A) LIN-61::GFP fusion proteins concentrate at nuclear foci, similar to HPL-2::GFP foci, as shown
by live fluorescent microscope images and zoomed in images of early embryos. (B) LIN-61::GFP foci fall into regions with low DAPI staining. Early
embryos expressing LIN-61::GFP were costained with an anti-GFP antibody and DAPI. The merged image represents a zoom-in of the boxed region in
the whole embryo and was contrast enhanced to highlight the localization of concentrated GFP foci in DAPI holes. Arrows point to LIN-61::GFP
negative nuclei, which have condensed chromatin and are likely undergoing mitosis. (C) LIN-13::GFP and LIN-61::3xFLAG fusion proteins localize to
overlapping nuclear foci. Embryos coexpressing both fusion proteins were costained with anti-GFP and anti-FLAG antibodies. A merged image that
zooms into the boxed region in the whole embryo is also shown. (D) LIN-61::GFP interacts with LIN-13 and HPL-2. Anti-GFP immunoprecipitate from
LIN-61::GFP expressing embryos was analyzed by mass spectrometry. Peptide coverage data for synMuv B heterochromatin class proteins were
shown. (E) LIN-13::GFP and HPL-2::GFP interact with LIN-61::3xFLAG protein in co-IP western assays. Only HPL-2::GFP showed interaction with LIN-
54::3xFLAG but the interaction was weaker compared to its interaction with LIN-61::3xFLAG. Each input lane represents 0.4% of material used in IP.
doi:10.1371/journal.pgen.1002542.g004
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WehaveshownthatsynMuvB classchromatinfactorsformthree
separate functional entities: the core DRM complex, the SUMO-
recruited Mec complex and the synMuv B heterochromatin
complex. Together, they inhibit the expression of germline and
RNAi genes in the soma to in turn inhibit RNAi. Misexpression of
germline genes in mutants lacking the heterochromatin class
synMuv B proteins strictly requires the germline chromatin factors
MES-4and MRG-1,suggesting an intimate antagonistic interaction
between them. In contrast, the misexpressions in DRM mutants
only partially depend on MES-4 and MRG-1, and thus require
additional master mediators for germline transcription. SynMuv B
proteins inhibit RNAi by repressing the expression of RNAi factors
as well as by other mechanisms. Our results point to a new means of
regulating RNAi potency and illustrate multiple activities required
for repressing germline gene expression in somatic cells (Figure S7).
synMuv B proteins uniquely inhibit RNAi
The synMuv B class genes inhibit RNAi using distinct
mechanisms from other eri genes. First, synMuv B mutations are
Figure 5. DRM and synMuv B heterochromatin class genes provide nonoverlapping functions. (A) DRM; synMuv B heterochromatin
double mutant animals showed further enhanced RNAi efficiency than either single null mutant, as shown by the increased penetrance of RNAi
phenotypes in double mutants (see Materials and Methods). (B) Additive upregulation of common targets in glp-4; hpl-2 or glp-4 lin-35 animals each
treated with additional synMuv B(RNAi). Real-time RT-PCR assays were performed on L4 stage animals and expression levels were each compared to
those in respective vector control RNAi treated animals. Asterisks represent a p-value of less than 0.05 in two-tailed t-tests.
doi:10.1371/journal.pgen.1002542.g005
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synMuv B heterochromatin double mutants are even more enhanced in
RNAi than either single mutant ([13] and XW, ZS and GR,
unpublished). Second, synMuv B proteins affect distinct aspects of
RNAi compared to proteins in the eri-1 pathway. Unlike eri-1
mutants, synMuv B mutants are not defective for the production of
eri-1-dependent endo small RNAs (XW, ZS and GR, unpub-
lished), and are normal for the eri-1-dependent nuclear localization
of the NRDE-3/Argonaute protein (MC and HM, unpublished).
synMuv B mutants, however, accumulate higher levels of siRNAs,
which did not occur in eri mutants. Taken together, synMuv B
proteins likely inhibit RNAi at a different step than Eri pathway
proteins. Rather than losing endogenous small RNA processes and
releasing shared factors to exogenous RNAi [61,62], as proposed
for the eri pathway, synMuv B proteins directly affect the
expression levels of RNAi factors.
synMuv B proteins may repress the expression of yet to be
identified RNAi factors in addition to those we have tested. This is
particularly likely given that the upregulated RNAi factors studied
here only partially mediate the enhanced RNAi phenotype.
Indeed, several other lin-35-responsive genes were positives in
previous screens for RNAi factors [56,63–65]. Specifically, cin-4,
spd-5 and lin-5 are required for dsRNA-mediated silencing of an
RNAi sensor [56]. rad-51 is required for RNAi-mediated
transcriptional gene silencing of a transgene [63]. rnp-8, kbp-3,
rsa-1 and vha-7 are required for tandem high copy transgene-
induced cosuppression of homologous endogenous gene [64],
while ucr-2.3 is required for transposon silencing [65]. Intriguingly,
six out of these nine genes encode proteins that are important for
chromosome biology during cell division (cin-4, spd-5, lin-5, rad-51,
kbp-3, and rsa-1), which again may reflect an intersection between
chromatin regulators and RNAi machinery.
Figure 6. mes-4/SET histone methyltransferase, a synMuv B suppressor, preferentially counteracts the activity of the synMuv B
heterochromatin class proteins. Real-time RT-PCR assays were performed using L4 stage worms with the indicated genotype and RNAi
treatment. Expression levels of a given target gene were compared to that of glp-4 worms treated with vector RNAi. Target genes were categorized
into (A) germline-specific common targets, (B) ubiquitously expressed common targets, (C) DRM-specific targets, (D) synMuv B heterochromatin and
MEP-1-LET-418 specific targets.
doi:10.1371/journal.pgen.1002542.g006
Figure 7. Transcriptional misregulations partially contribute to the enhanced RNAi response of synMuv B mutants. (A) Increased
accumulation of siRNA levels in synMuv B mutants. Animals with the indicated genotype were fed vector RNAi (V) or pos-1(RNAi) food (P) and pos-1
siRNA levels were measured by Northern blotting. U6 levels served as loading control. (B) Upregulated RNAi factors are partially required for
enhanced RNAi. Indicated mutants were fed lin-1(RNAi) and the percentage of Muv animals were scored in the second generation.
doi:10.1371/journal.pgen.1002542.g007
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than the misexpression of RNAi factors, as the effects of chromatin
go beyond transcriptional regulation. In support for this, many of
the chromatin-related synMuv suppressors are required for
efficient RNAi [11], suggesting that they may directly function
in RNAi and their activities may be affected by synMuv B
proteins. Among them, some may rescue the gene expression
defects (e.g., mes-4 and mrg-1), making it complicated to discern
their direct effects on RNAi. Others, however, may not rescue
target gene misexpression in somatic cells (e.g., zfp-1 and gfl-1), and
thus are more likely to function directly in RNAi mediated
silencing. Future work will be focused on establishing potential
physical interactions between synMuv B proteins and their
suppressors and possible functional regulations on one another.
Among synMuv B proteins, the DRM complex and the synMuv
B heterochromatin complex each distinctively inhibit RNAi. This
may involve the transcriptional regulation of common and unique
RNAi factors (as shown in this paper), or functional regulation of
specific chromatin-related RNAi factors. Further understanding
requires the identification of RNAi-related transcriptional as well
as functional targets that are specifically regulated by individual
synMuv B complexes.
Multiple pathways prevent the expression of germline-
specific genes in somatic cells
Our gene expression analysis of retinoblastoma pathway mutants
reveals transcriptional upregulation of a suite of germline-specific
genes in somatic cells of these mutant animals. More importantly,
we provided strong evidence pointing to nonredundant functions by
multiple synMuv B complexes, including the distinct subcellular
architectures of the misexpressed PGL-1 granules, the partially
nonoverlapping spectra of misexpression, and the genetic additivity
between them. Their differential interactions with MES-4 and
MRG-1 support their assignment to distinct pathways that prevent
somatic expression of germline genes (discussed later).
Inactivation of the insulin pathway or components of the CCT
cytosolic chaperonin complex also cause misexpression of germ-
line-specific genes in somatic cells [66]. Some of the dysregulation
in the daf-2 insulin pathway mutant may be through the inhibition
of the MEP-1-LET-418 Mec complex as a result of PIE-1
misexpression [17,66]. However, the somatic misexpressions in
daf-2 or cct mutants are much more modest than those in Mec
mutants, and are hypothesized to involve other factors in addition
to MES-4 and MRG-1 [66]. Thus, the insulin and cytosolic
chaperonin pathways may represent a parallel mechanism for
preventing germline gene expression in somatic cells. The
relationship between daf-2 and the DRM complex awaits more
investigation.
The misexpression of germline-specific genes in somatic cells of
animals lacking DRM function is extensive. Analogous microarray
experiments in the soma of Mec, synMuv B heterochromatin,
insulin and cct mutants will be necessary to disclose the full range of
misexpression upon losing these other pathways. Ultimately, these
misexpression profiles may help us understand the developmental
and physiological phenotypes unique to each mutant.
A refined model for repressing germline genes in the
soma
During C. elegans embryogenesis, primordial germline cells
(PGCs) and somatic cells are derived from the same mother cells
and both inherit MES-4/histone methyltransferase, whose activity
sets up a germline competent chromatin [41,67]. MES-4 binds to
genes that are expressed in the maternal germline, deposits RNA
pol II-independent histone H3K36 trimethylation and marks them
for germline expression in the current generation [41]. To prevent
germline genes from expression in the soma, somatic cells require
a mechanism to counteract the action of MES-4 until it gradually
disappears at about the 100-cell stage.
We propose that the Mec and synMuv B heterochromatin
complexes counteract MES-4 activity in somatic cells. This is
supported by the fact that for those germline targets affected by
these two complexes, MES-4 binds to all of them (Figure S3)
[41,67,68] and mediates all their misexpressions. These two
complexes may prevent the binding of MES-4 so that no new
H3K36me3 marks can be deposited, or, they may prevent the
recognition of MES-4-generated H3K36me3 marks. Our results
that mes-4 is also required for the misexpression of somatic targets,
which are normally not bound by MES-4 [68], suggests that
antagonizing MES-4 binding may be more likely. Thus, in the
absence of Mec and synMuv B heterochromatin complexes, MES-4
may spread to these somatic genes and erroneously mark them as
germline expressed. Directly analyzing the effects of Mec and
synMuv B heterochromatin complexes on MES-4 localization at
gene resolution by ChIP-chip and ChIP-seq techniques during
embryogenesis will distinguish between these two possibilities.
It was hypothesized that MEP-1-LET-418 antagonize MES-4
activity via the NuRD complex, since PIE-1, which interacts with
MEP-1-LET-418, inhibits the histone deacetylase activity of
HDA-1 in NuRD [17]. However, our results strongly suggest that
NuRD is not involved. Rather, MEP-1-LET-418 act as the Mec
complex in response to SUMO modification. Potentially, this also
involves the synMuv B heterochromatin complex, since LIN-61/
L3MBT was also shown to mediate SUMO-triggered transcrip-
tional repression [48].
It is unclear how the Mec and synMuv B heterochromatin
complexes might prevent MES-4 binding. One possibility is that
they change the structure and accessibility of chromatin, given that
LET-418/Mi-2 is an ATP-dependent nucleosome remodeling
factor while LIN-61/L3MBT and HPL-2/HP1 may cause higher
order chromatin compaction [5,55]. Alternatively, they may
prevent MES-4 binding by recruiting other factors that erase the
histone modifications recognized by MES-4 [69,70]. Analyzing the
states of histone modifications during normal repression vs.
misexpression might help to understand the mechanisms.
The result that DRM-specific targets are not suppressed by mes-
4 inactivation indicates that the DRM complex also functions
downstream of MES-4 or in a parallel pathway. The DRM
complex might be recruited to these target loci by sequence
specific DNA binding (e.g., by EFL-1/E2F or by LIN-54/Mip120)
and carry out repression. Indeed, among the 307 lin-35 L1 stage
up-regulated genes, 163 either contain E2F binding sites in their
promoter [44], or were reported to be bound by LIN-54 in a
ChIP-chip study [71], or both. Therefore, loss of DRM-mediated
repression at target promoters may account for much of the
misexpression that was observed. On the other hand, given the
vast extent of gene misexpression in lin-35 mutants, misexpression
may also involve antagonizing master regulators of germline
expression (e.g., other germline chromatin factors). Identifying
factors that specifically mediate the misexpressions in DRM
mutants may uncover novel master regulators of germline
expression.
It is interesting that the misexpressed germline genes are the
most detectable in intestine and hypodermis, suggesting that these
two tissues are the most prone to misexpression. This might be
caused by a difference in the initial MES-4-MRG-1 activity levels
or by a difference in the overall transcriptional activity and/or
chromatin configuration among different tissues. These two are
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that remain replication competent even towards the end of
developmental maturity (L4/adult molt) or even after that [72,73].
As such, they may maintain a different chromatin state than other
tissues, making them more susceptible to the action of germline
chromatin regulators, and rely more on Mec and synMuv B
heterochromatin complexes to prevent misexpression of germline
genes.
Relevance in general developmental and cancer biology
The function of LIN-35/Rb and other synMuv B chromatin
factors to prevent germline gene expression in the soma is likely
conserved in higher organisms. In Drosophila, misexpression of germ
granule and small RNA factors were also detected in Rb mutant
cells by microarray analyses [74] and in the brain tumors developed
in l(3)mbt (lin-61 homologue) mutant flies [75]. Future work to
understand the antagonistic relationship between synMuv B
complexes and MES-4-MRG-1 is crucial to understand the process
of repressing germline genes in the soma during development. In
addition, since the DRM complex functions beyond antagonizing
MES-4-MRG-1, identifying the unknown components specific to
the DRM pathway will likely uncover novel players that function in
this process.
Besides regulating the cell cycle, mammalian Rb also promotes
differentiation, and cancer cells are sometimes dedifferentiated
[76]. The expression of germline-specific genes in somatic cells in
worms and flies may be a form of dedifferentiation, and the role of
synMuv B genes to prevent that may be important for tumor
suppression. Consistent with this idea, the misexpressed germ
granule and small RNA factors were shown to be required for the
growth of the l(3)mbt mutant tumors [75]. Thus, the knowledge of
how Rb and other synMuv B chromatin complexes function to
prevent misexpression may contribute to our understanding of
cancer formation and the identification of new pathway
components may lead to the discovery of novel tumor suppressive
and oncogenic pathways.
Finally, the explicit mapping of C. elegans LIN-35/Rb and other
synMuv B chromatin factors to a regulatory pathway for
repression of germline encoded small RNA pathways suggests
that in some mammalian tumors, most especially the many that
bear Rb mutations, there may be specific enhancement of small
RNA pathways to empower the dedifferentiation of those tumors
towards more multipotent germline-like cells. A specific prediction
from our work is that one of the major transcriptional signatures of
Rb tumors should be misexpression of germline small RNA
cofactors and small RNAs themselves.
Materials and Methods
Worm strains and genetics
synMuv B alleles used in this study are listed in Figure S2. Other
alleles used are glp-4(bn2) I, smo-1(ok359) I, dcp-66(gk370) I, rrf-
1(pk1417) I, rrf-2(ok210) I, C04F12.1(tm1637) I, sago-2(tm894) I,
hT2[bli-4(e937) let-?(q782) qIs48] (I;III), szT1[lon-2(e678)] I;X, szT1
(I;X), dpy-18(e364) III, wago-9/C16C10.3(tm1200) III, dpy-17(e164)
III, eT1(III;V), eri-1(mg366) IV, nT1[qIs51] (IV;V), unc-46(e177) dpy-
11(e224) V, egr-1(gk255) V, chd-3(eh4) X.
Transgenic strains Is(sur-5::gfp) I, JR672 [wIs54(scm::gfp) V],
GR1403 [sur-5::gfp I; eri-1(mg366) IV], PD7271{pha-1(e2123) III;
ccEx7271[let-858::gfp pha-1(+)]}, GR1402 [eri-1(mg366) IV; wIs54
V] and FR463 [Is(HPL-2::GFP+pRF4)] were previously described
[32,56].
The LIN-61::GFP translational fusion consists, in order, of a
2.9 kb lin-61 genomic fragment containing the upstream intergenic
sequence and coding region minus the STOP codon, an engineered
sequence encoding a short peptide linker (GGAGGSAAA) followed
by GFP sequence amplified from pPD99.77, and then a 244 bp lin-
61 39 genomic fragment starting immediately after the STOP
codon. Extra chromosomal complex arrays were generated by
injectingwild type animals with a mixture of10 ng/ul LIN-61::GFP
fusion plasmid+1 ng/ul Pmyo-2::NLS::mCherry (gift from J. Bai and
J. Kaplan)+89 ng/ul sheared salmon sperm DNA. The LIN-
61::3xFLAG fusion was generated by replacing the GFP sequence
in LIN-61::GFP fusion construct with 3xFLAG sequence. LIN-
54::3xFLAG fusion consists of a 2.6 kb lin-54 genomic fragment
containing the upstream intergenic sequence and coding region
minus the STOP codon, the same short peptide linker followed by
3xFLAG sequence, and then a 413 bp lin-54 39 genomic fragment
starting immediately after the STOP codon. Extra chromosomal
complex arraysweregenerated byinjectingwild typeanimals with a
mixture of 10 ng/ul 3xFLAG fusion plasmid+1 ng/ul Pmec-
7::mRFP+89 ng/ul sheared salmon sperm DNA. All integrated
transgenic lines were obtained by UV irradiation, followed by six
times backcrossing.
LIN-13::GFP was reported to be a functional fusion gene [34].
All other translational fusion genes were tested to be rescuing
functional fusions (data not shown).
RNAi clones
RNAi clones targeting let-418, lin-13 and lin-15b were made by
individually cloning genomic fragments corresponding to part of
let-418 exon 5 (1025 bp), part of lin-13 exon 12 (727 bp) and part
of lin-15b exon 5 (1053 bp) into the NcoI site of the Ahringer
L4440 feeding vector. The other RNAi clones used were from the
Ahringer or Vidal libraries.
Transgene silencing assays
To measure Is(sur-5::gfp) expression, synchronized L1 animals of
the appropriate genotype were treated with RNAi at 15C till the
L3 stage of the same generation (P0 clones) or that of the second
generation (F1 clones) before scoring. The same was done to
measure wIs54(scm::gfp) expression, except that animals were
cultured at 22C and GFP was scored at the L4 stage. Germline
desilencing using PD7271 was assayed according to Kim et. al [56].
Immunostaining and microscopy
For PGL-1 misexpression, mutant or RNAi treated animals
were cultured at 22C for two generations (one generation for P0
RNAi treatment). PGL-1 immunostaining was performed as
described [13] with some modifications. Freeze-cracked slides
were immediately fixed at 220C in 100% methanol for
120 minutes, and then 100% acetone for 15 minutes. Larvae
were stained with monoclonal anti-PGL-1 antibody (K76) at 1:40
in PBSTB (PBS containing 0.1% Tween-20 and 1% BSA)
overnight at 4C, followed by Alexa Fluor-conjugated goat anti-
mouse IgM (Invitrogen) at 1:100 in PBST for 1 hour at 25C. After
washing with PBST, slides were mounted with Vectashield
mounting medium with DAPI (H-1200) and analyzed using a
Zeiss Axioplan2 microscope and Openlab imaging software.
Immunostainings of LIN-61::GFP, LIN-13::GFP and LIN-
61::3xFLAG in embryos were performed similarly. Rabbit
polyclonal anti GFP (Invitrogen A11122) and Sigma M2 anti-
FLAG were used at 1:1000 and 1:50, respectively. Alexa Fluor488-
conjugated goat anti-rabbit Ig G and Alexa Fluor594-conjugated
goat anti-mouse Ig G (Invitrogen) were both used at 1:100.
Toshow detailed PGL-1 granule morphology (Figure1D), stained
animalswerephotographed using aZeissImagerZ1microscopeand
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fifteen optical sections using algorism provided by the software.
Quantification of misexpression by real-time PCR
Synchronized L1 stage wild type, glp-4, and synMuv B; glp-4
animals were cultured at 25C till L4 stage before collection. For
one generation RNAi due to sterility (let-418 RNAi, smo-1 RNAi,
hda-1 RNAi), L1 stage glp-4 animals were dropped on RNAi food
and allowed to grow at 25C till L4 stage. For all other experiments
involving RNAi treatment, synchronized L1 stage glp-4 animals
were dropped onto RNAi food and cultured at 15C till gravid
adults with plateful of eggs. Adults and F1 larvae were washed off,
leaving the eggs behind. These eggs were allowed to hatch at 25C
for 3 hours. The newly hatched larvae were washed off,
transferred onto new plates with the same RNAi food and allowed
to grow to the L4 stage before collection.
Total RNA was isolated using Trizol (Invitrogen) and cDNA
was synthesized using Superscript III reverse transcriptase
(Invitrogen). Negative control without reverse transcriptase was
performed on a pooled sample of all the RNA samples under
study. Real time PCR reactions were performed using SYBR
green (BioRad). At least three biological replicate samples were
tested in triplicate. For each primer pair, a standard curve was
generated using serial dilutions of a pooled sample of all cDNA
templates involved. Relative quantities were deduced using the
standard curve. Fold changes of relative quantities were calculated
and normalized to rpl-32 and act-1. Fold differences for rpl-32 and
act-1 were less than two fold. Primer sequences are available upon
request.
Immunoprecipitation
Embryos were collected by hypochlorite treatment of gravid
adults and dropped into liquid nitrogen to freeze. Frozen pellets
were freeze ground to fine powder using a mortar and pestle and
1:6 resuspended in 50 mM HEPES pH 7.6, 140 mM KCl,
10 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 10% glycerol, 0.1%
b-octylglucoside, 0.5 mM BME, Complete Protease tablets
(Roche), 2 mM PMSF. Lysates were cleared by two centrifuga-
tions each at 150006 g for 20 min. Immunoprecipitation was
performed using monoclonal anti-GFP clone 3E6 (Invitrogen)
coupled to Affy ProA agarose beads (BioRad) at 4C for 2 hours.
Immunoprecipitates were washed using the same buffer. Bound
proteins were eluted using 0.1 M glycine (pH 2.5), and precipi-
tated using TCA. Pellets were washed with acetone, resuspended
in 50 mM NH4HCO3 and sent for mass spectrometry.
Immunoprecipitations for co-IP-Western analyses were per-
formed similarly, except that 50 ul packed embryos were used
and bound proteins were eluted from the anti-GFP matrix by
boiling in PAGE gel sample loading buffer. Eluted proteins were
analyzed by SDS-PAGE and Western analyses. Roche anti-GFP
(cat#11814460001), Sigma M2 anti-FLAG were used as primary
antibodies, Pierce peroxidase-conjugated goat anti-mouse IgG
antibody (cat#31430) and Pierce SuperSignal West Pico Extended
Duration chemiluminescent detection kit (cat#34076) were used.
RNAi feeding assay for additive Eri
For the diluted cel-1(RNAi) assay, OD600 matched cel-1(RNAi)
and vector RNAi cultures were mixed at 2:1 ratio by volume
before seeding plates. First day gravid adults reared on OP50 food
at 20C were exposed to RNAi food for 24 hours, then transferred
to new plates with the same food for a 4-hour egg lay. Afterwards,
adults were taken off the plate and laid embryos were allowed to
hatch and grow at 20C. L2 arrest was scored when animals of the
same genotype treated with only vector RNAi reached adulthood.
For the myo-2(RNAi) and his-14(RNAi) assays, synchronized L1
animals were treated with RNAi at 20C and were scored when
animals of the same genotype reached adulthood on vector RNAi.
Northern blotting
Synchronized L1 animals were dropped onto pos-1(RNAi) or
vector RNAi food and cultured at 20C until gravid adults with
plateful of eggs. Adults were collected and total RNA was isolated
using Trizol (Invitrogen). 60 ug of total RNA were used for each
sample. pos-1 siRNA was detected using body-labeled pos-1 probe
(Ambion MaxiScript kit). The stripped blot was reprobed with an
end-labeled U6 oligo probe. Hybridization signals were analyzed
using ImageQuant software and normalized to wild type samples.
Supporting Information
Figure S1 Summary of synMuv B gene classes based on
molecular and biochemical associations and previously reported
enhanced RNAi and PGL-1 misexpression phenotypes.
(TIF)
Figure S2 Summary of enhanced RNAi and PGL-1 misexpres-
sion phenotypes for synMuv B gene inactivations. Enhanced RNAi:
enhanced response to hmr-1(RNAi), unc-73(RNAi) and dpy-13(RNAi).
Transgene silencing: enhanced silencing of transgene arrays (sur-
5::gfp, scm::gfp and mgIS30). Transgene desilencing: desilencing of
transgenes arrays (sur-5::gfp and scm::gfp)i neri-1(mg366) background.
PGL-1 misexpression: somatic misexpression of PGL-1 detected by
anti-PGL-1 antibody staining.
(TIF)
Figure S3 (A) Extensive somatic expression of germline-specific
genes in lin-35 mutant animals as revealed by published microarray
experiments. (B) Summary of P granule and RNAi genes that were
upregulated in published microarray experiments.
(TIF)
Figure S4 Summary of target upregulations resulted from
synMuv B gene inactivations as measured by real-time RT-PCR
assays.
(TIF)
Figure S5 LIN-61::GFP associated proteins as revealed by silver-
staining with comparison to anti-GFP western.
(TIF)
Figure S6 synMuv B heterochromatin class proteins are
required for transgene silencing. (A) Fluorescent microscope
images showing the desilencing effect of lin-61(RNAi) on different
scenarios of transgene silencing (eri-1-induced, DRM-induced, and
natural germline silencing). (B) Summary of transgene desilencing
phenotypes upon RNAi inactivation of synMuv B heterochroma-
tin class genes as measured by GFP fluorescence for transgene
expression. 2: no desilencing effect detected compared to vector
RNAi control. +/2 to +++: different levels of desilencing, ranging
from marginal to strong.
(TIF)
Figure S7 A model for repression of germline P granule and
RNAi components in somatic cells by synMuv B genes.
(TIF)
Acknowledgments
We thank the CGC and Mitani lab for strains, the Mello lab (UMass
Worcester) and the Hybridoma Bank for the anti-PGL-1 antibody, and F.
Palladino for the HPL-2::GFP strain. We thank C. Riedel and A. Staller for
help on immunoprecipitation, S. Fischer for probes used in the pos-1
Chromatin Complexes Repress Germline RNAi Pathways
PLoS Genetics | www.plosgenetics.org 17 March 2012 | Volume 8 | Issue 3 | e1002542siRNA Northern, and other members of the Ruvkun lab for discussions
and comments on the manuscript. We thank J. Asara at the Beth Israel
Deaconess Medical Center Mass Spectrometry Core for performing the
Mass Spectrometry analyses and C. Riedel for analyzing the mass
spectrometry data.
Author Contributions
Conceived and designed the experiments: XW ZS MC MH GR.
Performed the experiments: XW ZS MC. Analyzed the data: XW ZS
MC MH GR. Contributed reagents/materials/analysis tools: XW ZS MC.
Wrote the paper: XW GR.
References
1. Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the
retinoblastoma gene. Nat Rev Cancer 8: 671–682.
2. van den Heuvel S, Dyson NJ (2008) Conserved functions of the pRB and E2F
families. Nat Rev Mol Cell Biol 9: 713–724.
3. Lewis PW, Beall EL, Fleischer TC, Georlette D, Link AJ, et al. (2004)
Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex.
Genes Dev 18: 2929–2940.
4. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, et al. (2001) Rb
targets histone H3 methylation and HP1 to promoters. Nature 412: 561–565.
5. Trojer P, Li G, Sims RJ, 3rd, Vaquero A, Kalakonda N, et al. (2007) L3MBTL1,
a histone-methylation-dependent chromatin lock. Cell 129: 915–928.
6. Longworth MS, Herr A, Ji JY, Dyson NJ (2008) RBF1 promotes chromatin
condensation through a conserved interaction with the Condensin II protein
dCAP-D3. Genes Dev 22: 1011–1024.
7. Sage J, Straight AF (2010) RB’s original CIN? Genes Dev 24: 1329–1333.
8. Cui M, Chen J, Myers TR, Hwang BJ, Sternberg PW, et al. (2006) SynMuv
genes redundantly inhibit lin-3/EGF expression to prevent inappropriate vulval
induction in C. elegans. Dev Cell 10: 667–672.
9. Ceol CJ, Stegmeier F, Harrison MM, Horvitz HR (2006) Identification and
classification of genes that act antagonistically to let-60 Ras signaling in
Caenorhabditis elegans vulval development. Genetics 173: 709–726.
10. Poulin G, Dong Y, Fraser AG, Hopper NA, Ahringer J (2005) Chromatin
regulation and sumoylation in the inhibition of Ras-induced vulval development
in Caenorhabditis elegans. Embo J 24: 2613–2623.
11. Cui M, Kim EB, Han M (2006) Diverse chromatin remodeling genes antagonize
the Rb-involved SynMuv pathways in C. elegans. PLoS Genet 2: e74.
doi:10.1371/journal.pgen.0020074.
12. Lehner B, Calixto A, Crombie C, Tischler J, Fortunato A, et al. (2006) Loss of
LIN-35, the Caenorhabditis elegans ortholog of the tumor suppressor p105Rb,
results in enhanced RNA interference. Genome Biol 7: R4.
13. Wang D, Kennedy S, Conte D, Jr., Kim JK, Gabel HW, et al. (2005) Somatic
misexpression of germline P granules and enhanced RNA interference in
retinoblastoma pathway mutants. Nature 436: 593–597.
14. Fischer SE, Butler MD, Pan Q, Ruvkun G (2008) Trans-splicing in C. elegans
generates the negative RNAi regulator ERI-6/7. Nature 455: 491–496.
15. Kennedy S, Wang D, Ruvkun G (2004) A conserved siRNA-degrading RNase
negatively regulates RNA interference in C. elegans. Nature 427: 645–649.
16. Petrella LN, Wang W, Spike CA, Rechtsteiner A, Reinke V, et al. (2011)
synMuv B proteins antagonize germline fate in the intestine and ensure C. elegans
survival. Development 138: 1069–1079.
17. Unhavaithaya Y, Shin TH, Miliaras N, Lee J, Oyama T, et al. (2002) MEP-1
and a homolog of the NURD complex component Mi-2 act together to maintain
germline-soma distinctions in C. elegans. Cell 111: 991–1002.
18. Strome S, Wood WB (1983) Generation of asymmetry and segregation of germ-
line granules in early C. elegans embryos. Cell 35: 15–25.
19. Updike D, Strome S (2009) P granule assembly and function in Caenorhabditis
elegans germ cells. J Androl 31: 53–60.
20. Claycomb JM, Batista PJ, Pang KM, Gu W, Vasale JJ, et al. (2009) The
Argonaute CSR-1 and its 22G-RNA cofactors are required for holocentric
chromosome segregation. Cell 139: 123–134.
21. Sheth U, Pitt J, Dennis S, Priess JR (2010) Perinuclear P granules are the
principal sites of mRNA export in adult C. elegans germ cells. Development 137:
1305–1314.
22. Updike DL, Hachey SJ, Kreher J, Strome S (2011) P granules extend the nuclear
pore complex environment in the C. elegans germ line. J Cell Biol 192: 939–948.
23. Andersen EC, Lu X, Horvitz HR (2006) C. elegans ISWI and NURF301
antagonize an Rb-like pathway in the determination of multiple cell fates.
Development 133: 2695–2704.
24. Takasaki T, Liu Z, Habara Y, Nishiwaki K, Nakayama J, et al. (2007) MRG-1,
an autosome-associated protein, silences X-linked genes and protects germline
immortality in Caenorhabditis elegans. Development 134: 757–767.
25. Seeler JS, Bischof O, Nacerddine K, Dejean A (2007) SUMO, the three Rs and
cancer. Curr Top Microbiol Immunol 313: 49–71.
26. Harrison MM, Ceol CJ, Lu X, Horvitz HR (2006) Some C. elegans class B
synthetic multivulva proteins encode a conserved LIN-35 Rb-containing
complex distinct from a NuRD-like complex. Proc Natl Acad Sci U S A 103:
16782–16787.
27. Korenjak M, Taylor-Harding B, Binne UK, Satterlee JS, Stevaux O, et al.
(2004) Native E2F/RBF complexes contain Myb-interacting proteins and
repress transcription of developmentally controlled E2F target genes. Cell 119:
181–193.
28. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, et al. (2007)
Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex
represses human cell cycle-dependent genes in quiescence. Mol Cell 26:
539–551.
29. Chen Z, Han M (2001) C. elegans Rb, NuRD, and Ras regulate lin-39-mediated
cell fusion during vulval fate specification. Curr Biol 11: 1874–1879.
30. Solari F, Ahringer J (2000) NURD-complex genes antagonise Ras-induced
vulval development in Caenorhabditis elegans. Curr Biol 10: 223–226.
31. Andersen EC, Horvitz HR (2007) Two C. elegans histone methyltransferases
repress lin-3 EGF transcription to inhibit vulval development. Development 134:
2991–2999.
32. Coustham V, Bedet C, Monier K, Schott S, Karali M, et al. (2006) The C. elegans
HP1 homologue HPL-2 and the LIN-13 zinc finger protein form a complex
implicated in vulval development. Dev Biol 297: 308–322.
33. Harrison MM, Lu X, Horvitz HR (2007) LIN-61, one of two Caenorhabditis elegans
malignant-brain-tumor-repeat-containing proteins, acts with the DRM and
NuRD-like protein complexes in vulval development but not in certain other
biological processes. Genetics 176: 255–271.
34. Melendez A, Greenwald I (2000) Caenorhabditis elegans lin-13, a member of the
LIN-35 Rb class of genes involved in vulval development, encodes a protein with
zinc fingers and an LXCXE motif. Genetics 155: 1127–1137.
35. Clark SG, Lu X, Horvitz HR (1994) The Caenorhabditis elegans locus lin-15,a
negative regulator of a tyrosine kinase signaling pathway, encodes two different
proteins. Genetics 137: 987–997.
36. Hsieh J, Liu J, Kostas SA, Chang C, Sternberg PW, et al. (1999) The RING
finger/B-box factor TAM-1 and a retinoblastoma-like protein LIN-35 modulate
context-dependent gene silencing in Caenorhabditis elegans. Genes Dev 13:
2958–2970.
37. Huang LS, Tzou P, Sternberg PW (1994) The lin-15 locus encodes two negative
regulators of Caenorhabditis elegans vulval development. Mol Biol Cell 5: 395–411.
38. Thomas JH, Horvitz HR (1999) The C. elegans gene lin-36 acts cell autonomously
in the lin-35 Rb pathway. Development 126: 3449–3459.
39. Couteau F, Guerry F, Muller F, Palladino F (2002) A heterochromatin protein 1
homologue in Caenorhabditis elegans acts in germline and vulval development.
EMBO Rep 3: 235–241.
40. Tseng RJ, Armstrong KR, Wang X, Chamberlin HM (2007) The bromodomain
protein LEX-1 acts with TAM-1 to modulate gene expression in C. elegans. Mol
Genet Genomics 278: 507–518.
41. Rechtsteiner A, Ercan S, Takasaki T, Phippen TM, Egelhofer TA, et al. (2010)
The histone H3K36 methyltransferase MES-4 acts epigenetically to transmit the
memory of germline gene expression to progeny. PLoS Genet 6: e1001091.
doi:10.1371/journal.pgen.1001091.
42. Bessler JB, Andersen EC, Villeneuve AM (2010) Differential localization and
independent acquisition of the H3K9me2 and H3K9me3 chromatin modifica-
tions in the Caenorhabditis elegans adult germ line. PLoS Genet 6: e1000830.
doi:10.1371/journal.pgen.1000830.
43. Grishok A, Hoersch S, Sharp PA (2008) RNA interference and retinoblastoma-
related genes are required for repression of endogenous siRNA targets in
Caenorhabditis elegans. Proc Natl Acad Sci U S A 105: 20386–20391.
44. Kirienko NV, Fay DS (2007) Transcriptome profiling of the C. elegans Rb
ortholog reveals diverse developmental roles. Dev Biol 305: 674–684.
45. Reinke V, Gil IS, Ward S, Kazmer K (2004) Genome-wide germline-enriched
and sex-biased expression profiles in Caenorhabditis elegans. Development 131:
311–323.
46. Wang X, Zhao Y, Wong K, Ehlers P, Kohara Y, et al. (2009) Identification of
genes expressed in the hermaphrodite germ line of C. elegans using SAGE. BMC
Genomics 10: 213.
47. Kunert N, Wagner E, Murawska M, Klinker H, Kremmer E, et al. (2009) dMec:
a novel Mi-2 chromatin remodelling complex involved in transcriptional
repression. Embo J 28: 533–544.
48. Stielow B, Sapetschnig A, Kruger I, Kunert N, Brehm A, et al. (2008)
Identification of SUMO-dependent chromatin-associated transcriptional repres-
sion components by a genome-wide RNAi screen. Mol Cell 29: 742–754.
49. Leight ER, Glossip D, Kornfeld K (2005) Sumoylation of LIN-1 promotes
transcriptional repression and inhibition of vulval cell fates. Development 132:
1047–1056.
50. Belfiore M, Mathies LD, Pugnale P, Moulder G, Barstead R, et al. (2002) The
MEP-1 zinc-finger protein acts with MOG DEAH box proteins to control gene
expression via the fem-3 39 untranslated region in Caenorhabditis elegans. Rna 8:
725–739.
51. Ceol CJ, Horvitz HR (2001) dpl-1 DP and efl-1 E2F act with lin-35 Rb to
antagonize Ras signaling in C. elegans vulval development. Mol Cell 7: 461–473.
52. Lu X, Horvitz HR (1998) lin-35 and lin-53, two genes that antagonize a C. elegans
Ras pathway, encode proteins similar to Rb and its binding protein RbAp48.
Cell 95: 981–991.
Chromatin Complexes Repress Germline RNAi Pathways
PLoS Genetics | www.plosgenetics.org 18 March 2012 | Volume 8 | Issue 3 | e100254253. von Zelewsky T, Palladino F, Brunschwig K, Tobler H, Hajnal A, et al. (2000)
The C. elegans Mi-2 chromatin-remodelling proteins function in vulval cell fate
determination. Development 127: 5277–5284.
54. Koester-Eiserfunke N, Fischle W (2011) H3K9me2/3 binding of the MBT
domain protein LIN-61 is essential for Caenorhabditis elegans vulva development.
PLoS Genet 7: e1002017. doi:10.1371/journal.pgen.1002017.
55. Lomberk G, Wallrath L, Urrutia R (2006) The Heterochromatin Protein 1
family. Genome Biol 7: 228.
56. Kim JK, Gabel HW, Kamath RS, Tewari M, Pasquinelli A, et al. (2005)
Functional genomic analysis of RNA interference in C. elegans. Science 308:
1164–1167.
57. Noma K, Sugiyama T, Cam H, Verdel A, Zofall M, et al. (2004) RITS acts in cis
to promote RNA interference-mediated transcriptional and post-transcriptional
silencing. Nat Genet 36: 1174–1180.
58. Motamedi MR, Hong EJ, Li X, Gerber S, Denison C, et al. (2008) HP1 proteins
form distinct complexes and mediate heterochromatic gene silencing by
nonoverlapping mechanisms. Mol Cell 32: 778–790.
59. Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, et al. (2001) On the role of
RNA amplification in dsRNA-triggered gene silencing. Cell 107: 465–476.
60. Yigit E, Batista PJ, Bei Y, Pang KM, Chen CC, et al. (2006) Analysis of the C.
elegans Argonaute family reveals that distinct Argonautes act sequentially during
RNAi. Cell 127: 747–757.
61. Duchaine TF, Wohlschlegel JA, Kennedy S, Bei Y, Conte D, Jr., et al. (2006)
Functional proteomics reveals the biochemical niche of C. elegans DCR-1 in
multiple small-RNA-mediated pathways. Cell 124: 343–354.
62. Lee RC, Hammell CM, Ambros V (2006) Interacting endogenous and
exogenous RNAi pathways in Caenorhabditis elegans. Rna 12: 589–597.
63. Grishok A, Sinskey JL, Sharp PA (2005) Transcriptional silencing of a transgene
by RNAi in the soma of C. elegans. Genes Dev 19: 683–696.
64. Robert VJ, Sijen T, van Wolfswinkel J, Plasterk RH (2005) Chromatin and
RNAi factors protect the C. elegans germline against repetitive sequences. Genes
Dev 19: 782–787.
65. Vastenhouw NL, Fischer SE, Robert VJ, Thijssen KL, Fraser AG, et al. (2003) A
genome-wide screen identifies 27 genes involved in transposon silencing in C.
elegans. Curr Biol 13: 1311–1316.
66. Curran SP, Wu X, Riedel CG, Ruvkun G (2009) A soma-to-germline
transformation in long-lived Caenorhabditis elegans mutants. Nature 459:
1079–1084.
67. Furuhashi H, Takasaki T, Rechtsteiner A, Li T, Kimura H, et al. (2010) Trans-
generational epigenetic regulation of C. elegans primordial germ cells. Epigenetics
Chromatin 3: 15.
68. Celniker SE, Dillon LA, Gerstein MB, Gunsalus KC, Henikoff S, et al. (2009)
Unlocking the secrets of the genome. Nature 459: 927–930.
69. Bender LB, Suh J, Carroll CR, Fong Y, Fingerman IM, et al. (2006) MES-4: an
autosome-associated histone methyltransferase that participates in silencing the
X chromosomes in the C. elegans germ line. Development 133: 3907–3917.
70. Lin CH, Li B, Swanson S, Zhang Y, Florens L, et al. (2008) Heterochromatin
protein 1a stimulates histone H3 lysine 36 demethylation by the Drosophila
KDM4A demethylase. Mol Cell 32: 696–706.
71. Tabuchi TM, Deplancke B, Osato N, Zhu LJ, Barrasa MI, et al. (2011)
Chromosome-biased binding and gene regulation by the Caenorhabditis elegans
DRM complex. PLoS Genet 7: e1002074. doi:10.1371/journal.pgen.1002074.
72. Flemming AJ, Shen ZZ, Cunha A, Emmons SW, Leroi AM (2000) Somatic
polyploidization and cellular proliferation drive body size evolution in
nematodes. Proc Natl Acad Sci U S A 97: 5285–5290.
73. Hedgecock EM, White JG (1985) Polyploid tissues in the nematode Caenorhabditis
elegans. Dev Biol 107: 128–133.
74. Georlette D, Ahn S, MacAlpine DM, Cheung E, Lewis PW, et al. (2007)
Genomic profiling and expression studies reveal both positive and negative
activities for the Drosophila Myb MuvB/dREAM complex in proliferating cells.
Genes Dev 21: 2880–2896.
75. Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C (2010) Ectopic
expression of germline genes drives malignant brain tumor growth in Drosophila.
Science 330: 1824–1827.
76. Daley GQ (2008) Common themes of dedifferentiation in somatic cell
reprogramming and cancer. Cold Spring Harb Symp Quant Biol 73: 171–174.
Chromatin Complexes Repress Germline RNAi Pathways
PLoS Genetics | www.plosgenetics.org 19 March 2012 | Volume 8 | Issue 3 | e1002542